Crimean-Congo hemorrhagic fever treated with ribavirin in a pregnant woman
Authors:
- Murat DizbayMDMurat Dizbay
- Firdevs AktasFAFirdevs Aktas
- Ummugulsum GaygisizUGUmmugulsum Gaygisiz
- Hasan Selcuk OzgerHOHasan Selcuk Ozger
- Kevser OzdemirKOKevser Ozdemir
- 31 October 2009
- journal article
- case report
- Published by Elsevier in Journal of Infection
- Vol. 59 (4) , 281-283
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of Crimean-Congo hemorrhagic feverAntiviral Research, 2008
- Viral Load as a Predictor of Outcome in Crimean-Congo Hemorrhagic FeverClinical Infectious Diseases, 2007
- Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisitedClinical Microbiology and Infection, 2006
- The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in IranClinical Infectious Diseases, 2003
- No evidence for mutagenic effects of ribavirin: report of two normal pregnanciesAmerican Journal of Gastroenterology, 2001
- Ebola Hemorrhagic Fever and PregnancyThe Journal of Infectious Diseases, 1999
- Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infectionAntiviral Research, 1993
- Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal SyndromeThe Journal of Infectious Diseases, 1991
- A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy.BMJ, 1988
- Teratogenic effects of ribavirin on hamster and rat embryosTeratology, 1978